EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Circular RNAs in obesity and related metabolic disorders: mechanistic insights and therapeutic perspectives

Daniela Bernal-Vázquez, Ignacio Bolaños-Fernández, Gabriel O Salcedo-Rivas, Marcela Figueroa-Ramírez, Asim K Duttaroy, Sujay Paul

Frontiers in Genetics · 10.04.2026 · 17

DOI: 10.3389/fgene.2026.1763596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Genetics, online erschienen am 10.04.2026. Verfasst von Daniela Bernal-Vázquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tecnologico de Monterrey, School of Engineering and Sciences, Campus Querétaro, Querétaro, Mexico. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a multifactorial and chronic metabolic disease strongly linked to type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular complications, and several cancers. Despite advances in pharmacological and surgical interventions, long-term management remains suboptimal, emphasizing the need for new molecular targets. Circular RNAs (circRNAs), a unique class of covalently closed non-coding RNAs, have recently emerged as critical regulators of metabolic homeostasis. By acting as microRNA sponges, transcriptional modulators, and protein scaffolds, circRNAs participate in key processes such as adipogenesis, lipid metabolism, inflammation, and insulin signaling. Dysregulated circRNA expression has been implicated in obesity-induced β-cell dysfunction, hepatic steatosis, vascular remodeling, and tumor progression. Their high stability, evolutionary conservation, and tissue-specific expression further highlight their promise as minimally invasive biomarkers and therapeutic candidates for obesity-associated disorders. However, translation to clinical application remains limited due to methodological inconsistencies, lack of standardized quantification, and insufficient functional validation. Future integration of circRNA profiling with multi-omics and genome-editing approaches could accelerate the identification of mechanistic pathways and therapeutic targets, paving the way for precision medicine strategies in obesity and related metabolic diseases.

Schlagwörter

Stichwörter der Autor:innen

biomarkercircular RNAmetabolic disordersnon-coding RNAobesitytherapeutic

Autor:innen und Institutionen

  • Tecnologico de Monterrey, School of Engineering and Sciences, Campus Querétaro, Querétaro, Mexico.
  • Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.

Zitieren

APA

Bernal-Vázquez, D., Bolaños-Fernández, I., Salcedo-Rivas, G. O., Figueroa-Ramírez, M., Duttaroy, A. K., & Paul, S. (2026). Circular RNAs in obesity and related metabolic disorders: mechanistic insights and therapeutic perspectives. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1763596

Vancouver

Bernal-Vázquez D, Bolaños-Fernández I, Salcedo-Rivas GO, Figueroa-Ramírez M, Duttaroy AK, Paul S. Circular RNAs in obesity and related metabolic disorders: mechanistic insights and therapeutic perspectives. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1763596

BibTeX
@article{BernalVzquez2026,
  author = {Bernal-Vázquez, Daniela and Bolaños-Fernández, Ignacio and Salcedo-Rivas, Gabriel O and Figueroa-Ramírez, Marcela and Duttaroy, Asim K and Paul, Sujay},
  title = {Circular RNAs in obesity and related metabolic disorders: mechanistic insights and therapeutic perspectives},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1763596}
}
Kostenlos starten →